Literature DB >> 21413864

Breast cancer and bone mineral density: the Marburg Breast Cancer and Osteoporosis Trial (MABOT II).

M Kalder1, C Jäger, B Seker-Pektas, K Dinas, I Kyvernitakis, P Hadji.   

Abstract

OBJECTIVES: The current case-control study is the first to examine the relationship between bone mineral density (BMD) measured by dual-energy X-ray absorptiometry (DXA) and quantitative ultrasonometry (QUS) in pre- as well as postmenopausal women with breast cancer compared to healthy matched controls.
METHODS: Among 1422 women (premenopausal, n = 238, postmenopausal, n = 1184), BMD and QUS were measured. In total, 541 of the women had an incident diagnosis of breast cancer (122 premenopausal, 419 postmenopausal) without prior breast cancer treatment. Because of significant intergroup differences in multiple risk factors, a matched-pair analysis (88 premenopausal and 402 postmenopausal women with and without breast cancer) was performed. Additionally, a multiple linear regression analysis was undertaken, odds ratios were determined and subjects grouped according to quartiles of DXA and QUS results.
RESULTS: DXA results (except the L1-L4 Z-score) were significantly higher in postmenopausal women with breast cancer even after a matched-pair analysis was performed (p < 0.05). In premenopausal women, we observed no significant differences in DXA results between the groups. QUS results in pre- and postmenopausal women with breast cancer were significantly higher compared with their matched controls (p < 0.001 for all, except for speed of sound in premenopausal patients, p < 0.05). Odds ratios for breast cancer risk in the second, third and fourth quartiles compared with the lowest quartile were significantly different for a number of variables.
CONCLUSIONS: Our results showed significantly higher BMD irrespective of the method and site of measurement in postmenopausal women with breast cancer compared to controls, even after matching for possible confounders for the first time.

Entities:  

Mesh:

Year:  2011        PMID: 21413864     DOI: 10.3109/13697137.2011.557754

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  13 in total

1.  The Relationship between Bone Mineral Density and Estrogen Receptor Positivity in Patients with Breast Cancer.

Authors:  Zeynep Erdoğan İyigün; Kezban Nur Pilancı; Fatmagül Kuşku Çabuk; Serkan İlgün; Çetin Ordu; Tomris Duymaz; Gül Alço; Filiz Çelebi; Dauren Sarsenov; Filiz İzci; Alper Öztürk; Filiz Ağaçayak; Ülkühan İner Köksal; Fatma Aktepe; Yeşim Eralp; Vahit Özmen
Journal:  J Breast Health       Date:  2016-07-01

2.  Association between prior cancer diagnosis and osteoporosis: a matched case-control study.

Authors:  Shuman Yang; Na Wang; Jianmeng Wang; Lisa M Lix; William D Leslie; Baoming Yuan
Journal:  Arch Osteoporos       Date:  2022-08-12       Impact factor: 2.879

3.  Influence of compliance on bone mineral density changes in postmenopausal women with early breast cancer on Anastrozole.

Authors:  Matthias Kalder; Volker Ziller; Ioannis Kyvernitakis; Dana Knöll; Olaf Hars; Peyman Hadji
Journal:  J Cancer Res Clin Oncol       Date:  2013-02-27       Impact factor: 4.553

4.  Breast cancer and osteoporosis - management of cancer treatment-induced bone loss in postmenopausal women with breast cancer.

Authors:  Matthias Kalder; Peyman Hadji
Journal:  Breast Care (Basel)       Date:  2014-10       Impact factor: 2.860

Review 5.  Identifying opportunities for cancer prevention during preadolescence and adolescence: puberty as a window of susceptibility.

Authors:  Frank M Biro; Julianna Deardorff
Journal:  J Adolesc Health       Date:  2013-05       Impact factor: 5.012

6.  HIF signaling in osteoblast-lineage cells promotes systemic breast cancer growth and metastasis in mice.

Authors:  Claire-Sophie Devignes; Yetki Aslan; Audrey Brenot; Audrey Devillers; Koen Schepers; Stéphanie Fabre; Jonathan Chou; Amy-Jo Casbon; Zena Werb; Sylvain Provot
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-16       Impact factor: 11.205

7.  Does adjuvant chemotherapy change bone mineral density and related serum biomarkers in women with breast cancer?

Authors:  Reza Safaei-Nodehi; Javad Esmaili; Ramazanali Sharifian; Shafieh Movaseghi; Sayeh Parkhideh
Journal:  Caspian J Intern Med       Date:  2017

8.  Analyses of the association between breast cancer and osteoporosis/fracture history: a cross-sectional study using KoGES HEXA data.

Authors:  Hyo Geun Choi; Yong Joon Suh; Jung Woo Lee; Chan Yang Min; Dae Myoung Yoo; Suk Woo Lee
Journal:  Arch Osteoporos       Date:  2021-06-19       Impact factor: 2.617

9.  Association between bone mineral density and incidence of breast cancer.

Authors:  Merav Fraenkel; Victor Novack; Yair Liel; Michael Koretz; Ethel Siris; Larry Norton; Tali Shafat; Shraga Shany; David B Geffen
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

10.  Bone mineral density and breast cancer risk: Results from the Vorarlberg Health Monitoring & Prevention Program and meta-analysis.

Authors:  G Nagel; R S Peter; E Klotz; W Brozek; H Concin
Journal:  Bone Rep       Date:  2017-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.